DNA-ploidy abnormalities are a reflection of the metastatic potential of malignant melanoma. Microfluorometric DNA analysis

Acta Dermato-Venereologica

Volumn 77, Issue 2, 1997, Pages 118-121

  Umebayashi, Yoshihiro ^a   Otsuka, Fujio ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

metastasis

Indexed keywords

DNA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; MELANOMA; METASTASIS; METASTASIS POTENTIAL; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; CYTOPHOTOMETRY; DNA, NEOPLASM; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MELANOMA; MIDDLE AGED; MULTIVARIATE ANALYSIS; PLOIDIES; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SKIN NEOPLASMS;

EID: 0030952113     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Mackie RM, Carfrae DC, Frei E. Assessment of prognosis in patients with malignant melanoma. Lancet 1972; 2: 455-456.
2. Barclay TL, Crockett DJ, Eastwood DS, Eastwood J, Giles GR. Assessment of prognosis in cutaneous malignant melanoma. Br J Surg 1977; 64: 54-58.
3. Büchner TH, Hiddemann B, Wörmann B, Kleinemeier B, Schumann J, Göhde W, et al. Differential pattern of DNA-aneuploidy in human malignancies. Path Res Pract 1985; 179: 310-317.
4. Barlogie B, Raber MN, Schumann J, Johnson TS, Drewinko B, Swartzendruber DE, et al. Flow cytometry in clinical cancer research. Cancer Res 1983; 43: 3982-3997.
5. Friedlander ML, Hedley DW, Taylor IW. Clinical and biological significance of aneuploidy in human tumours. J Clin Pathol 1984; 37: 961-974.
6. Søndergaard K, Larsen JK, Møller U, Christensen IJ, Hou-Jensen K. DNA-ploidy-characteristics of human malignant melanoma analyzed by flow cytometry and compared with histology and clinical course. Virchows Arch [Cell Pathol] 1983; 42: 43-52.
7. Wass J, Zbroja RA, Young GAR, Vincent PC, Joyce RM, Croaker G. Malignant melanoma: analysis by DNA flow cytometry. Pathology 1985; 17: 475-480.
8. Hansson J, Tribukait B, Lewensohn R, Ringborg U. Flow cytometric DNA analyses of metastases of human malignant melanomas. Anal Quant Cytol 1982; 67: 99-104.
9. Björnhagen V, Erhardt K, Lagerlöf B, Auer G. Comparison of nuclear DNA content in primary and metastatic malignant melanoma. Anal Quant Cytol Histol 1991; 13: 343-350.
10. Rode J, Williams RA, Charlton IG, Dhillon AP, Moss E. Nuclear DNA profiles in primary melanomas and their metastases. Cancer 1991; 67: 2333-2336.
11. Chi H-I, Ishibashi Y, Shima A, Mihara I, Otsuka F. Use of DAPI cytofluorometric analysis of cellular DNA content to differentiate Spitz nevus from malignant melanoma. J Invest Dermatol 1990; 95: 154-157.
12. Otsuka F, Chi H-I, Umebayashi Y. Successful differentiation of Spitz naevus from malignant melanoma by microfluorometric analysis of cellular DNA content. Clin Exp Dermatol 1993; 18: 421-424.
13. Umebayashi Y, Otsuka F. Prognostic significance in malignant melanoma of nuclear DNA content measured by microfluorometric methods. Arch Dermatol Res 1995; 287: 718-722.
14. Clark WH Jr. A classification of malignant melanoma in man correlated with histogenesis and biologic behavior. In: Montagna W, Hu F, eds. Advances in biology of the skin. Vol VIII. Oxford: Pergamon Press, 1967: 621-647.
15. Clark WH Jr., From L, Bernardino EA, Mihm MC. The histogenesis and biologic behavior of primary human malignant melanoma of the skin. Cancer Res 1969; 29: 705-715.
16. Otsuka F, Shima A, Ishibashi Y. Porokeratosis as a premalignant condition of the skin: cytologic demonstration of abnormal DNA ploidy in cells of the epidermis. Cancer 1989; 63: 891-896.
17. Chi HI, Uyeda Y, Umebayashi Y, Otsuka F. Epithelioid cell melanomas have greater DNA ploidy abnormalities than spindle cell melanomas: cytologic evidence for a higher malignant potential of the former. Arch Dermatol Res 1993; 285: 410-414.
18. Auer G, Fallenius A, Erhardt K, Sundelin B. Progression of mammary adenocarcinomas as reflected by nuclear DNA-content. Cytometry 1984; 5: 420-425.
19. Erhardt K, Auer G. Mammary carcinoma: comparison of nuclear DNA content from in situ and infiltrative components. Anal Quant Cytol Histol 1987; 9: 263-267.
20. Erhardt K, Auer G. Mammary carcinoma: comparison of nuclear DNA content in the primary tumor and corresponding axillary lymph node metastases. Acta Pathol Microbiol Immunol Scand [A] 1986; 94: 29-34.
21. Bäckdahl M, Cohn K, Auer G, Forsslund G, Granberg P-O, Lundell G, et al. Comparison of nuclear DNA-content in primary and metastatic papillary thyroid carcinoma. Cancer Res 1985; 45: 2890-2894.
22. Weiss L, Poste G. The tumor cell periphery In: Symington T, Carter RL, eds. Scientific foundations of oncology. London: William Heinemann Medical Books, 1976: 25-35.